InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
2
T+90 hit rate
20%
T+90 mean return
-8.9%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Foster-Cheek Kaye I, Director. Director active across 2 companies, notably AGIOS PHARMACEUTICALS, INC.. In total, 10 filings have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €46k. History available since 28 May 2021. The latest transaction was filed on 13 June 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations10 total
2,816 sharesCommon stockSEC:0001439222-26-000103:0
3,388 shares0Common stockSEC:0001439222-24-000091:0
1,285 shares@ US$31.628.1% of flowCommon stockSEC:0001439222-24-000061:0
300 shares@ US$32.211.9% of flowCommon stockSEC:0001439222-24-000058:0
25,000 shares@ US$18.0989.9% of flowCommon stockSEC:0001439222-23-000125:0
4,975 shares0Common stockSEC:0001439222-23-000097:0
2,200 shares0Common stockSEC:0001439222-23-000006:0
1,585 shares0Common stockSEC:0001439222-22-000048:0
1,686 shares0Common stockSEC:0001439222-21-000053
1,686 shares0Common stockSEC:0001439222-21-000053:0
10 of 10 declarations
About Foster-Cheek Kaye I
Kaye I. Foster-Cheek is a Director at Agios Pharmaceuticals, Inc. She contributes to the governance of the company and strategic decision-making. Her expertise in the pharmaceutical sector allows her to provide valuable insights into regulatory and innovation challenges.
